Cargando…

Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum

Detalles Bibliográficos
Autores principales:	Sheth, Jay, Anantharaman, Giridhar, Kumar, Nilesh, Parachuri, Nikulaa, Bandello, Francesco, Kuppermann, Baruch D., Loewenstein, Anat, Sharma, Ashish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608197/ https://www.ncbi.nlm.nih.gov/pubmed/32327739 http://dx.doi.org/10.1038/s41433-020-0886-0

Ejemplares similares

Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020)

Brolucizumab and immunogenicity
por: Sharma, Ashish, et al.
Publicado: (2020)

Commentary: Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
por: Anantharaman, Giridhar
Publicado: (2019)

Smartphone based ROP (S-ROP) screening—opportunities and challenges
por: patil, Jayaprakash, et al.
Publicado: (2020)

Commentary: Pachydrusen: A tell-tale sign of pachychoroid phenotype
por: Saurabh, Kumar, et al.
Publicado: (2020)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Macular neovascularization in eyes with pachydrusen
por: Teo, Kelvin Yi Chong, et al.
Publicado: (2021)

Commentary: Low incidence of pachydrusen in central serous chorioretinopathy in an Indian cohort
por: Sheth, Jay U
Publicado: (2020)

Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Pachydrusen in Indian population: A hospital-based study
por: Singh, Sumit Randhir, et al.
Publicado: (2019)

Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India
por: Sharma, Ashish, et al.
Publicado: (2022)

Low incidence of pachydrusen in central serous chorioretinopathy in an Indian cohort
por: Singh, Sumit Randhir, et al.
Publicado: (2020)

Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists
por: Sharma, Ashish, et al.
Publicado: (2023)

Comment on: Validating the pachychoroid disease spectrum using multimodal imaging
por: Sheth, Jay U, et al.
Publicado: (2019)

Multimodal Imaging of Subfoveal Pachydrusen Containing a Blood Flow Signal
por: Ishiguro, Naoko, et al.
Publicado: (2022)

Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
por: Fukuda, Yoshiko, et al.
Publicado: (2019)

Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2020)

Association of Fundus Autofluorescence Abnormalities and Pachydrusen in Central Serous Chorioretinopathy and Polypoidal Choroidal Vasculopathy
por: Lai, Timothy Y. Y., et al.
Publicado: (2022)

”Double-layer sign” on spectral domain optical coherence tomography in pachychoroid spectrum disease
por: Sheth, Jay, et al.
Publicado: (2018)

Ranizurel safety evaluation in real-world -(RaSER) study
por: Sharma, Ashish, et al.
Publicado: (2022)

Population-Based Prevalence and 5-Year Change of Soft Drusen, Pseudodrusen, and Pachydrusen in a Japanese Population
por: Sato-Akushichi, Miki, et al.
Publicado: (2021)

The Association of Pachydrusen Characteristics with Choroidal Thickness and Patient’s Age in Polypoidal Choroidal Vasculopathy versus Central Serous Chorioretinopathy
por: Kim, Young Ho, et al.
Publicado: (2022)

Commentary: Acute central serous chorioretinopathy – Treat early, observe longer
por: Kumar, Nilesh, et al.
Publicado: (2021)

Ophthalmic biosimilars: Lessons from India
por: Sharma, Ashish, et al.
Publicado: (2019)

Correction: Comment on: ‘Recent advances in anterior chamber angle imaging’
por: Kumar, Nilesh, et al.
Publicado: (2020)

Comment on: ‘Recent advances in anterior chamber angle imaging’
por: Kumar, Nilesh, et al.
Publicado: (2020)

Biosimilars in ophthalmology: “Is there a big change on the horizon?”
por: Sharma, Ashish, et al.
Publicado: (2018)

Pachychoroid Spectrum Disorders: An Updated Review
por: B. Brown, Richard, et al.
Publicado: (2023)

Bilateral choroidal caverns in a child with pachychoroid and anxious personality
por: Pederzolli, Matteo, et al.
Publicado: (2022)

Validating the pachychoroid disease spectrum using multimodal imaging
por: Ayachit, Guruprasad, et al.
Publicado: (2018)

Pulsation of anastomotic vortex veins in pachychoroid spectrum diseases
por: Matsumoto, Hidetaka, et al.
Publicado: (2021)

Hydrodynamic Analysis of the Clinical Findings in Pachychoroid-Spectrum Diseases
por: Nishi, Okihiro, et al.
Publicado: (2022)

Imaging Characteristics of Neovascular and Atrophic Pachychoroidal Spectrum Diseases
por: Hua, Rui, et al.
Publicado: (2022)

Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions
por: Soman, Manoj, et al.
Publicado: (2021)

Serous macular detachment in nanophthalmos: A manifestation of pachychoroid spectrum
por: Kumar, Vinod, et al.
Publicado: (2019)

Current diagnosis and management strategies in pachychoroid spectrum of diseases (Review)
por: Moraru, Andreea Dana, et al.
Publicado: (2020)

Simultaneous multiple pachychoroid spectrum entities coexisting in the same eye
por: Manayath, George J, et al.
Publicado: (2020)

Pachychoroid Spectrum Disorder Findings in Patients with Coronavirus Disease 2019
por: Abrishami, Mojtaba, et al.
Publicado: (2021)

Commentary: Double-layer sign” on spectral domain optical coherence tomography in pachychoroid spectrum disease
por: Chhablani, Jay, et al.
Publicado: (2019)

Management of recalcitrant polypoidal choroidal vasculopathy by feeder vessel laser photocoagulation
por: Sheth, Jay, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vbvoe59pev8abl4nh7gsgf0kpe